| 1 |
34718178 | A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer. | 2022 Jan 1 |
3 |
| 2 |
35192728 | Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance. | 2022 Mar |
1 |
| 3 |
33390536 | Functional Alterations of Multidrug Resistance-Associated Proteins 2 and 5, and Breast Cancer Resistance Protein upon Snail-Induced Epithelial-Mesenchymal Transition in HCC827 Cells. | 2021 |
4 |
| 4 |
33569416 | Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells. | 2021 Jan |
2 |
| 5 |
34502348 | The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. | 2021 Aug 30 |
3 |
| 6 |
34680166 | Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant Eremophila galeata Chinnock. | 2021 Oct 18 |
4 |
| 7 |
34830383 | A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo. | 2021 Nov 19 |
1 |
| 8 |
31889589 | Cetuximab enhances the efficiency of irinotecan through simultaneously inhibiting the MAPK signaling and ABCG2 in colorectal cancer cells. | 2020 Feb |
2 |
| 9 |
31975441 | Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines. | 2020 Apr |
1 |
| 10 |
32143347 | The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP. | 2020 Mar 4 |
1 |
| 11 |
32326511 | An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. | 2020 Apr 15 |
1 |
| 12 |
32708825 | ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer. | 2020 Jul 16 |
4 |
| 13 |
33158067 | Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells. | 2020 Nov 4 |
1 |
| 14 |
33692943 | Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line. | 2020 |
2 |
| 15 |
30925062 | Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach. | 2019 May 9 |
2 |
| 16 |
27845419 | ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. | 2018 Jan |
1 |
| 17 |
29246888 | Impact of Breast Cancer Resistance Protein Expression on the In Vitro Efficacy of Anticancer Drugs in Pancreatic Cancer Cell Lines. | 2018 Mar |
3 |
| 18 |
29486476 | Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells. | 2018 |
1 |
| 19 |
29518481 | Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo. | 2018 Jun 28 |
1 |
| 20 |
30075623 | 2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2. | 2018 Sep 13 |
1 |
| 21 |
30166404 | Gene-by-Environment Interaction of Bcrp-/- and Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition. | 2018 Nov |
8 |
| 22 |
30367935 | β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer. | 2018 Dec |
1 |
| 23 |
28120346 | 2-Trifluoromethyl-2-Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)-Mediated Multidrug Resistance: Synthesis and Biological Evaluations. | 2017 Aug |
2 |
| 24 |
28131876 | Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib. | 2017 May |
1 |
| 25 |
28880238 | Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review. | 2017 Sep 7 |
6 |
| 26 |
28904007 | Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2. | 2017 Nov |
1 |
| 27 |
28948511 | SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells. | 2017 Dec |
2 |
| 28 |
29016119 | 9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein. | 2017 Nov 9 |
1 |
| 29 |
26719532 | Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer. | 2016 Mar 1 |
5 |
| 30 |
26801902 | Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines. | 2016 Jan 22 |
4 |
| 31 |
27207776 | Combining ABCG2 Inhibitors with IMMU-132, an Anti-Trop-2 Antibody Conjugate of SN-38, Overcomes Resistance to SN-38 in Breast and Gastric Cancers. | 2016 Aug |
1 |
| 32 |
27269636 | Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysis. | 2016 Jun |
1 |
| 33 |
27280693 | Synthesis and Investigation of Tetrahydro-β-carboline Derivatives as Inhibitors of the Breast Cancer Resistance Protein (ABCG2). | 2016 Jul 14 |
1 |
| 34 |
27698852 | ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan. | 2016 Oct |
8 |
| 35 |
25855895 | HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). | 2015 May 14 |
1 |
| 36 |
26206183 | Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia. | 2015 Sep 1 |
2 |
| 37 |
26352872 | ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients. | 2015 Dec |
1 |
| 38 |
26386386 | Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer. | 2015 Nov 1 |
1 |
| 39 |
26516354 | ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer. | 2015 |
2 |
| 40 |
26692923 | FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models. | 2015 |
3 |
| 41 |
24462359 | Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells. | 2014 Apr |
2 |
| 42 |
24523596 | Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics. | 2014 |
6 |
| 43 |
24726739 | Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance. | 2014 Jun |
1 |
| 44 |
24781822 | Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer. | 2014 Apr 30 |
1 |
| 45 |
24932285 | Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers. | 2014 Jun |
2 |
| 46 |
24959385 | Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer? | 2014 |
4 |
| 47 |
25083297 | Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy. | 2014 Aug |
3 |
| 48 |
25195021 | Development and validation of an ultra-high performance LC-MS/MS assay for intracellular SN-38 in human solid tumour cell lines: comparison with a validated HPLC-fluorescence method. | 2014 Oct 15 |
2 |
| 49 |
25368234 | Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11. | 2014 Nov |
7 |
| 50 |
22882086 | A template model for studying anticancer drug efflux transporter inhibitors in vitro. | 2013 Oct |
6 |